CM Life Sciences III (CMLTU) to Combine with EQRx in $3.5Bn Deal
Warning: DOMDocument::loadHTML(): Unexpected end tag : p in Entity, line: 5 in /var/convesio/wordpress/wp-content/plugins/spacinsider-upqode/src/Start.php on line 90
CMLS III (NASDAQ:CMLTU) has entered into a definitive agreement to combine with biotech firm EQRx at an enterprise value of $3.54 billion. Cambridge, Massachusetts-based EQRx is developing a range of drug candidates both generated in-house and licensed from peers with an aim to reducing the overall cost of pharmaceutical rollouts. The combined company is expected
Read More
To access this post, you must purchase 1 - User: Monthly Plan.